Merck & Co. (MRK)
(Delayed Data from NYSE)
$97.92 USD
-2.78 (-2.76%)
Updated Jan 17, 2025 04:00 PM ET
After-Market: $97.95 +0.03 (0.03%) 7:58 PM ET
3-Hold of 5 3
B Value B Growth F Momentum B VGM
Industry / Sector Report
Industry : Large Cap Pharmaceuticals
Zacks Industry Rank
Bottom 13% (217 out of 250)Zacks Sector Rank
Top 6% (1 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 1.52 | 2.04 | 9.99 |
Current Quarter Estimate | 1.76 | 34.67 | 61.00 |
Year Ago Quarter Estimate | 0.03 | 10.25 | 53.90 |
Next Quarter Estimate | 2.25 | 41.23 | NA |
Next Year Estimate | 9.44 | 175.36 | 277.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | 409.93 | 6.50 | 12.40 |
Next Year | 22.60 | 10.60 | 15.25 |
Last 5 Years | -19.90 | 2.90 | 8.10 |
Next 5 Years | 9.00 | 12.00 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | 16.46 | 21.12 |
Price/Book (MRQ) | 5.57 | 4.98 |
Price/Cash Flow (MRFY) | 32.19 | 10.40 |
Dividend Yield | 3.31% | 2.39% |
Net Profit Margin (TTM) | 19.23% | NA |
Return on Equity (TTM) | 36.42% | NA |
Debt to Equity (MRQ) | NA | NA |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.